Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126553282 | 12655328 | 2 | F | 20160723 | 20160805 | 20160816 | 20160816 | EXP | PK-SA-2016SA145281 | AVENTIS | 55.00 | YR | A | F | Y | 0.00000 | 20160816 | CN | PK | PK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126553282 | 12655328 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE- 30-32 IU | UNK | 21081 | QD | ||||||||
| 126553282 | 12655328 | 2 | C | DIAMICRON | GLICLAZIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126553282 | 12655328 | 1 | Type 2 diabetes mellitus |
| 126553282 | 12655328 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126553282 | 12655328 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126553282 | 12655328 | Decreased appetite | |
| 126553282 | 12655328 | Dizziness | |
| 126553282 | 12655328 | Hyperglycaemia | |
| 126553282 | 12655328 | Insomnia | |
| 126553282 | 12655328 | Irritability | |
| 126553282 | 12655328 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126553282 | 12655328 | 1 | 201606 | 0 |